Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ASCO Highlights.NEW YORK -- Bristol-Myers Squibb Company (NYSE NYSE See: New York Stock Exchange : BMY BMY Bristol Myers Squibb ) will host a conference call at 4:30 p.m. (ET) on Monday, June 2 to review data presented at the 44th Annual Meeting of the American Society of Clinical Oncology American Society of Clinical Oncology, or ASCO, is an organization that represents all clinical oncologists. Every year, ASCO holds a large symposium where physicians and researchers meet to convey and discuss research and ideas. (ASCO ASCO American Society of Clinical Oncology ASCO Association of Schools and Colleges of Optometry (since 1941; Rockville, Maryland) ASCO Australian Standard Classification of Occupations ASCO Automatic Switch Company ), being held from May 30-June 2 in Chicago. Company executives will provide an overview of data presented at the meeting on the oncology portfolio and address inquiries from investors and analysts. Investors and the general public are invited to listen to a live webcast of the call at http://www.bms.com/ir or by dialing 913-312-1388, confirmation code: 6849982. A replay of the call will be available beginning at 8:30 p.m. (ET) on June 2 through midnight (ET) on June 16. The replay can be accessed at http://www.bms.com/ir or by dialing 402-280-9013, confirmation code: 6849982. Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to extend and enhance human life. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion